Does TOLODODEKIN ALFA Cause Disease progression? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Disease progression have been filed in association with TOLODODEKIN ALFA. This represents 4.3% of all adverse event reports for TOLODODEKIN ALFA.
24
Reports of Disease progression with TOLODODEKIN ALFA
4.3%
of all TOLODODEKIN ALFA reports
3
Deaths
6
Hospitalizations
How Dangerous Is Disease progression From TOLODODEKIN ALFA?
Of the 24 reports, 3 (12.5%) resulted in death, 6 (25.0%) required hospitalization, and 5 (20.8%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOLODODEKIN ALFA. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does TOLODODEKIN ALFA Cause?
Off label use (81)
Neutropenia (59)
Plasma cell myeloma (52)
Thrombocytopenia (48)
Anaemia (44)
Drug ineffective (44)
Infusion related reaction (42)
Pneumonia (37)
Pyrexia (34)
Febrile neutropenia (31)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TOLODODEKIN ALFA Alternatives Have Lower Disease progression Risk?
TOLODODEKIN ALFA vs TOLTERODINE
TOLODODEKIN ALFA vs TOLVAPTAN
TOLODODEKIN ALFA vs TOPAMAX
TOLODODEKIN ALFA vs TOPIRAMATE
TOLODODEKIN ALFA vs TOPOTECAN